Infinity Market Research
Infinity Market Research

Global Live Attenuated Influenza Vaccine (LAIV) Market Growth 2025-2031


Sep 2025

Healthcare

Pages: 115

LPI10960

PDF Available
Word Available
Excel Available


The global Live Attenuated Influenza Vaccine (LAIV) market size is predicted to grow from US$ 8858 million in 2025 to US$ 12950 million in 2031; it is expected to grow at a CAGR of 6.5% from 2025 to 2031.


A Live Attenuated Influenza Vaccine (LAIV), also known as the nasal spray or intranasal flu vaccine, is a type of influenza vaccine that is designed to provide immunity against the influenza virus. Unlike traditional injectable influenza vaccines, which contain inactivated (killed) virus particles, LAIV contains a weakened, live influenza virus. This live virus is attenuated, meaning it has been modified to reduce its virulence (ability to cause disease) while still retaining the capacity to stimulate an immune response.


Evolving Vaccine Formulations: The LAIV formulation changes annually to match the prevalent influenza virus strains. Researchers continually monitor and adapt the vaccine to ensure it provides protection against the most relevant strains. This requires ongoing research and development efforts.


Preference for Non-Invasive Vaccination: The nasal spray administration method of LAIV is preferred by some individuals, particularly children and those who are averse to needles. This preference has driven demand for LAIV, especially among pediatric populations.


Efficacy and Effectiveness Research: Ongoing research is aimed at improving the effectiveness and stability of LAIV. Ensuring the vaccines effectiveness is crucial in maintaining public confidence and its role in influenza prevention.


Enhanced Cold Chain Management: As LAIV is a live vaccine, it requires specific storage and transport conditions to maintain its viability. Advances in cold chain management are essential to preserve the vaccines effectiveness.


Global Variations in Approval: Approval and recommendations for LAIV can vary by country and region. Some countries may be more enthusiastic about LAIV, while others may have specific guidelines and restrictions regarding its use.


Infinity Market Research newest research report, the ?Live Attenuated Influenza Vaccine (LAIV) Industry Forecast? looks at past sales and reviews total world Live Attenuated Influenza Vaccine (LAIV) sales in 2024, providing a comprehensive analysis by region and market sector of projected Live Attenuated Influenza Vaccine (LAIV) sales for 2025 through 2031. With Live Attenuated Influenza Vaccine (LAIV) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Live Attenuated Influenza Vaccine (LAIV) industry.


This Insight Report provides a comprehensive analysis of the global Live Attenuated Influenza Vaccine (LAIV) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Live Attenuated Influenza Vaccine (LAIV) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Live Attenuated Influenza Vaccine (LAIV) market.


This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Live Attenuated Influenza Vaccine (LAIV) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Live Attenuated Influenza Vaccine (LAIV).


This report presents a comprehensive overview, market shares, and growth opportunities of Live Attenuated Influenza Vaccine (LAIV) market by product type, application, key manufacturers and key regions and countries.


Segmentation by Type:


    Trivalent Flu Vaccine
    Quadrivalent Flu Vaccine


Segmentation by Application:


    Hospital
    Clinic
    Public Health Agency
    Other


This report also splits the market by region:


    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries


The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.


    Sanofi Pasteur
    AstraZeneca
    CSL
    Abbott
    GlaxoSmithKline
    Serum Institute
    Fluenz Tetra
    Cytiva
    BioDiem
    FluMist
    GSK
    ChangChun High & New Technology
    BCHT Biotechnology


Key Questions Addressed in this Report


What is the 10-year outlook for the global Live Attenuated Influenza Vaccine (LAIV) market?
What factors are driving Live Attenuated Influenza Vaccine (LAIV) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Live Attenuated Influenza Vaccine (LAIV) market opportunities vary by end market size?
How does Live Attenuated Influenza Vaccine (LAIV) break out by Type, by Application?

Live Attenuated Influenza Vaccine Market Scope

Report AttributeDetails
Market Size (Start Year)USD XX Million
Market Size (End Year)USD XX Million
Compound Annual Growth Rate (CAGR)USD XX Million
Forecast PeriodUSD XX Million
Base YearUSD XX Million
Historical DataUSD XX Million
Key PlayersUSD XX Million

📘 Frequently Asked Questions

1. What is the market size of Global Live Attenuated Influenza Vaccine Market?

Answer: The global Live Attenuated Influenza Vaccine (LAIV) market size is predicted to grow from US$ 8858 million in 2025 to US$ 12950 million in 2031; it is expected to grow at a CAGR of 6.5% from 2025 to 2031.

2. Which regions are analyzed in the Global Live Attenuated Influenza Vaccine Market report?

Answer: The Global Live Attenuated Influenza Vaccine Market report covers major regions such as Europe, Middle East & Africa. Each region is analyzed for trends, opportunities, and market dynamics.

3. What methodology is used for forecasting of Global Live Attenuated Influenza Vaccine Market?

Answer: The Global Live Attenuated Influenza Vaccine Market report uses a mix of primary research, secondary data, and expert analysis to build its forecasts. Models include both qualitative and quantitative approaches.

4. Are emerging markets analyzed separately in the Global Live Attenuated Influenza Vaccine Market?

Answer: Yes, the Global Live Attenuated Influenza Vaccine Market report highlights high-growth emerging regions with dedicated insights. These include untapped opportunities, risks, and potential for expansion.

5. Does the report include competitive benchmarking of Global Live Attenuated Influenza Vaccine Market?

Answer: Yes, Global Live Attenuated Influenza Vaccine Market report compares major players based on revenue, product portfolio, innovation, and regional presence. This helps assess competitive positioning.

6. Can I access country-level data within the Global Live Attenuated Influenza Vaccine Market report?

Answer: Yes, Global Live Attenuated Influenza Vaccine Market report includes detailed data by country, especially for key markets. This allows for localized insights and decision-making.

7. Can I get customized insights or data from the Global Live Attenuated Influenza Vaccine Market report?

Answer: Yes, we offer customization options to align with your specific business needs. You can request tailored sections or regional breakdowns.

🎁 This Month Only: Flat $1000 OFF

Enjoy an exclusive $1000 discount on every report purchased this month. No code needed.

Secure payment methods

🔐 Secure Payment Guaranteed

Safe checkout with trusted global payment methods.

🌟 Why Choose Infinity Market Research?

  • Accurate & Verified Data:Our insights are trusted by global brands and Fortune 500 companies.
  • Complete Transparency:No hidden fees, locked content, or misleading claims — ever.
  • 24/7 Analyst Support:Our expert team is always available to help you make smarter decisions.
  • Instant Savings:Enjoy a flat $1000 OFF on every report.
  • Fast & Reliable Delivery:Get your report delivered within 5 working days, guaranteed.
  • Tailored Insights:Customized research that fits your industry and specific goals.

📄 Available License Types

👤 Single User
$3660
$2660
👥 Multi User
$5490
$4490
🏢 Enterprise User
$7320
$6320
Buy Now
Secure payment methods

Recent Reports

Laboratory Degassers Market

Global Laboratory Degassers market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Laboratory Funnel Market

Global Laboratory Funnel market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.